Gordon Ringold
Chief Executive Officer en Alavita Pharmaceuticals, Inc. .
Fortuna: - $ al 31/03/2024
Perfil
Gordon Ringold is the founder of Maxygen, Inc. (founded in 1997) and SurroMed, Inc. (founded in 1997).
He held the title of Independent Director at Maxygen, Inc. from 2011 to 2013 and Chairman & Chief Executive Officer at SurroMed, Inc. from 1997 to 2005.
Dr. Ringold currently holds multiple positions.
He is the Executive Chairman & Chief Executive Officer at Alavita Pharmaceuticals, Inc. since 2000.
He is also the Chief Executive Officer & Director at Quadriga BioSciences, Inc., Chairman at Maverix Biomics, Inc., Director at Protein Metrics, Inc., Director at Okava Pharmaceuticals, Inc., Director at Rapafusyn Pharmaceuticals, and Managing Partner at Technogen Associates LP.
In his former positions, Dr. Ringold served as the Chief Executive Officer at Affymax Research Institute from 1995 to 2000.
He was also the Chairman of Nanoplex Technologies, Inc. and Director-Cancer Biology at Syntex Corp.
from 1986 to 2010.
Additionally, he held the role of Independent Director at Alexza Pharmaceuticals, Inc. from 2001 to 2016, Non-Executive Director at Oxonica Ltd.
in 2005, Senior Director at the University of California, Santa Cruz from 2010 to 2013, Independent Director at Sagimet Biosciences, Inc. from 2009 to 2023, Independent Director at Ardelyx, Inc. from 2014 to 2021, and Independent Director at Apexigen, Inc. from 2020 to 2023.
Dr. Ringold's education includes an undergraduate degree from the University of California, Santa Cruz and a doctorate degree from the University of California, San Francisco.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/07/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Gordon Ringold
| Empresas | Cargo | Inicio |
|---|---|---|
Alavita Pharmaceuticals, Inc.
 Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Chief Executive Officer | 01/01/2005 |
Maverix Biomics, Inc.
 Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Maverix Biomics, Inc. provides cloud-based platform to manage, analyze and visualize genomic data. It also builds communities of discovery and place its data in context with the latest public data from the full spectrum of life, including human, plant, animal or microbial organisms. The company was founded by David Mandelkern, Todd Michael Johnson Lowe and Patricia Pak Lee Chan in 2010 and is headquartered in San Mateo, CA. | Chairman | - |
| Technogen Associates LP | Corporate Officer/Principal | - |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Chief Executive Officer | 01/01/2015 |
Protein Metrics, Inc.
 Protein Metrics, Inc. Information Technology ServicesTechnology Services Part of Insightful Science Holdings LLC, Protein Metrics, Inc. is a private company that specializes in protein characterization. The company is based in Cupertino, CA at the crossroads of computing and biotechnology. The company's vendor-neutral software enables scientists to quickly identify and report protein sequences and variations from the expected form using data generated on analytical instruments like mass spectrometers. The company was founded by Yong Kil, Marshall Bern, Chris Becker, and Eric Carlson has been the CEO of the company since 2014. Protein Metrics was acquired by Insightful Science Holdings LLC on December 21, 2021. | Director/Board Member | - |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Director/Board Member | 04/06/2020 |
Okava Pharmaceuticals, Inc.
 Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Okava Pharmaceuticals, Inc. is an American clinical stage biotechnology company. | Director/Board Member | - |
| Rapafusyn Pharmaceuticals | Director/Board Member | - |
Antiguos cargos conocidos de Gordon Ringold.
| Empresas | Cargo | Fin |
|---|---|---|
| APEXIGEN, INC. | Director/Board Member | 23/08/2023 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Formación de Gordon Ringold.
| University of California, Santa Cruz | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| Empresas privadas | 15 |
|---|---|
| Syntex Corp. | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Commercial Services |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Nanoplex Technologies, Inc.
 Nanoplex Technologies, Inc. BiotechnologyHealth Technology Nanoplex Technologies, Inc. used to produce encoded nanoparticles. It developed nanomaterial to be used in chemical and biochemical sensing, called SERS nanotags. The company was founded by Michael Natan and was located in Mountain View, CA. | Health Technology |
Alavita Pharmaceuticals, Inc.
Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Health Technology |
Protein Metrics, Inc.
Protein Metrics, Inc. Information Technology ServicesTechnology Services Part of Insightful Science Holdings LLC, Protein Metrics, Inc. is a private company that specializes in protein characterization. The company is based in Cupertino, CA at the crossroads of computing and biotechnology. The company's vendor-neutral software enables scientists to quickly identify and report protein sequences and variations from the expected form using data generated on analytical instruments like mass spectrometers. The company was founded by Yong Kil, Marshall Bern, Chris Becker, and Eric Carlson has been the CEO of the company since 2014. Protein Metrics was acquired by Insightful Science Holdings LLC on December 21, 2021. | Technology Services |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Commercial Services |
Oxonica Ltd.
 Oxonica Ltd. Miscellaneous Commercial ServicesCommercial Services Oxonica Ltd. is an advanced materials business, which engages in licensing of patents related to nanomaterials. The company was founded in 1999 and is headquartered in Birmingham, the United Kingdom. | Commercial Services |
SurroMed, Inc.
 SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Commercial Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
Maverix Biomics, Inc.
Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Maverix Biomics, Inc. provides cloud-based platform to manage, analyze and visualize genomic data. It also builds communities of discovery and place its data in context with the latest public data from the full spectrum of life, including human, plant, animal or microbial organisms. The company was founded by David Mandelkern, Todd Michael Johnson Lowe and Patricia Pak Lee Chan in 2010 and is headquartered in San Mateo, CA. | Commercial Services |
| Technogen Associates LP | |
Quadriga BioSciences, Inc.
Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Health Technology |
Okava Pharmaceuticals, Inc.
Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Okava Pharmaceuticals, Inc. is an American clinical stage biotechnology company. | Health Technology |
| Rapafusyn Pharmaceuticals |
- Bolsa de valores
- Insiders
- Gordon Ringold
